Sleep

Sleep disorders encompass a wide range of conditions that negatively affect an individual’s ability to achieve sufficient or restorative sleep.

These disorders can significantly impair daily functioning and health outcomes, contributing to cognitive decline, mood disturbances, and an increased risk of chronic diseases. Sleep disorders may be short-term (acute) or long-lasting (chronic) and are among the most common reasons for seeking medical intervention.

Common Conditions Related to Sleep Disorders

The most prevalent sleep disorders include:

  • Insomnia: Difficulty falling asleep, staying asleep, or waking too early. Insomnia can be acute (lasting days or weeks) or chronic, persisting for months or even years.
  • Sleep Apnoea: A condition where breathing repeatedly stops and starts during sleep. The most common form, obstructive sleep apnoea (OSA), causes fragmented sleep and reduced oxygen levels.
  • Restless Legs Syndrome (RLS): An uncontrollable urge to move the legs during sleep, often accompanied by uncomfortable sensations, which disrupts sleep quality.
  • Narcolepsy: A chronic condition marked by excessive daytime drowsiness and sudden sleep attacks.
  • Circadian Rhythm Disorders: Disruptions in the body’s internal clock, such as delayed sleep phase syndrome (difficulty falling asleep and waking up on time) or shift work disorder.
  • Parasomnias: Abnormal movements, behaviours, or emotions during sleep, including sleepwalking, night terrors, and REM sleep behaviour disorder (RBD).

Conventional Treatments for Sleep Disorders

Sleep disorders are typically managed with a combination of lifestyle modifications, cognitive behavioural therapy (CBT), and medications. Common treatments include:

Medications:

  • Hypnotics and Sedatives: Drugs such as Zolpidem (Ambien), Eszopiclone (Lunesta), and Zaleplon (Sonata) promote sleep but may cause dependency or tolerance with prolonged use.
  • Benzodiazepines: Medications like Diazepam or Lorazepam are sometimes prescribed for sleep disorders but carry a high risk of dependence and can interfere with sleep architecture.
  • Melatonin Receptor Agonists: Ramelteon (Rozerem) helps regulate the sleep-wake cycle, particularly for circadian rhythm disorders.
  • Antidepressants: Trazodone and Doxepin are often prescribed off-label for insomnia due to their sedative properties.
  • Stimulants: Drugs like Modafinil and Methylphenidate are used to treat daytime drowsiness associated with narcolepsy.

Non-Medication Approaches:

  • Continuous Positive Airway Pressure (CPAP): A machine used to keep airways open in patients with sleep apnoea.

While these treatments can be effective, they often come with side effects, including grogginess, cognitive impairment, tolerance, and dependency. Many patients seek alternatives due to these drawbacks or because their sleep disorders are resistant to conventional therapies.

How Cannabis Can Help

Medical cannabis, particularly cannabidiol (CBD) and tetrahydrocannabinol (THC), has shown promise in addressing various sleep disorders, especially insomnia and sleep apnoea. Cannabis interacts with the body’s endocannabinoid system (ECS), which regulates sleep-wake cycles, mood, and overall homeostasis.

Cannabinoids and Sleep Disorder Management: Clinical Evidence

Insomnia

  • A 2019 study in The Permanente Journal found that 66.7% of participants reported improved sleep scores after one month of CBD use, suggesting its potential to alleviate insomnia and improve sleep quality.
  • A 2021 systematic review in Frontiers in Psychology highlighted that low doses of THC could reduce sleep latency (time to fall asleep) and improve overall sleep duration. However, the review noted that effects vary based on cannabinoid ratios, dosage, and individual responses.
  • A 2018 study in Sleep Medicine Reviews highlighted that CBD can improve sleep by addressing underlying causes such as anxiety and pain, without the sedative effects of traditional sleep aids.

Sleep Apnoea

  • A 2013 study in Frontiers in Psychiatry investigated the effects of synthetic cannabinoids (dronabinol) on patients with sleep apnoea. Results showed a reduction in apnoea episodes and improved overall sleep quality.
  • A 2018 clinical trial published in Sleep demonstrated that dronabinol significantly reduced the severity of obstructive sleep apnoea, offering a potential new approach to treatment. However, further research is needed on the role of natural cannabis for sleep apnoea.

Restless Legs Syndrome (RLS)

  • A 2017 case report in Sleep Medicine documented that medical cannabis provided immediate relief for patients with RLS, improving sleep quality and reducing leg movements during the night.
  • Studies suggest that cannabinoids may interact with the dopaminergic system, which is often implicated in RLS, providing a potential mechanism for symptom relief.

Narcolepsy

  • Emerging evidence suggests that CBD can help regulate daytime wakefulness and improve night-time sleep quality in narcoleptic patients.
  • A 2017 study in Current Neurology and Neuroscience Reports indicated that cannabis may enhance nighttime sleep while promoting daytime alertness, offering potential benefits for managing narcoleptic symptoms.

Circadian Rhythm Disorders

  • A 2020 review in Cannabis and Cannabinoid Research found that CBD could help regulate circadian rhythms by interacting with receptors that influence the sleep-wake cycle. It may benefit conditions like shift work disorder or jet lag by promoting better sleep at night and reducing daytime fatigue.

Parasomnias (e.g., Sleepwalking, REM Sleep Behaviour Disorder)

  • Case studies published in Frontiers in Neurology have shown that CBD may reduce the frequency of parasomnias such as REM Sleep Behaviour Disorder (RBD), where individuals act out their dreams. Patients reported fewer disruptive movements and improved sleep quality.

Mechanisms of Action

Cannabis influences sleep and sleep disorders through the endocannabinoid system (ECS), particularly via CB1 and CB2 receptors. Key mechanisms include:

  • THC: Known for its sedative properties, THC can reduce the time needed to fall asleep and may extend deep sleep stages. However, prolonged use or high doses of THC may suppress REM sleep, the dream stage critical for cognitive health.
  • CBD: CBD alleviates anxiety, pain, and restlessness, which often interfere with sleep. Unlike THC, CBD promotes wakefulness during the day and improves sleep quality without causing dependency.
  • Endocannabinoid Modulation: Cannabinoids regulate the sleep-wake cycle by interacting with the hypothalamus (which controls circadian rhythms) and the serotonergic system (which affects mood, anxiety, and sleep).

Advantages Over Conventional Treatments

Cannabis-based therapies offer several benefits compared to traditional sleep medications:

  • Lower Dependency Risk: Cannabis, particularly CBD-dominant formulations, has a lower risk of dependency and tolerance compared to benzodiazepines or hypnotics.
  • Fewer Side Effects: Unlike traditional sleep aids, which can cause grogginess or cognitive impairment, CBD has a favourable side effect profile, with only mild fatigue or dry mouth reported in most cases.
  • Comprehensive Relief: Cannabis addresses the root causes of sleep disorders, such as anxiety, pain, or restless legs, rather than merely sedating the patient.

Conclusion

Medical cannabis, particularly CBD and THC, shows significant potential for managing a range of sleep disorders, including insomnia, sleep apnoea, restless legs syndrome, and parasomnias. By interacting with the endocannabinoid system, cannabis can improve sleep quality, regulate circadian rhythms, and address the underlying causes of sleep disturbances.

With its favourable side effect profile and growing evidence base, medical cannabis provides a promising alternative for patients seeking long-term relief from sleep disorders. By adhering to strict regulatory frameworks, healthcare providers can ensure safe and effective access to cannabis-based therapies for patients in need.

Subscribe for AKOS communications